www.bioscience.co.uk
Sales & Support: +44 (0)1223 316 855

*

Fevipiprant

Catalogue number:
CAY20263-5 mg
Supplier:
Size:
5 mg
Product is available in:
  • UK
  • Ireland
  • Europe
  • USA
  • Rest of World
£591.00 Estimated delivery Wed 26 Nov
Shipping is calculated in checkout
This product is for research use only and is not for human consumption or therapeutic use.
CAS Number:

872365-14-5

Purity:

≥98%

Formulation:

A crystalline solid

Molecular Formula:

C19H17F3N2O4S

Molecular Weight:

426.4

Alternative Names:

2-methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1 h -pyrrolo[2,3b]pyridine-3-acetic acid, nvp-qaw039, qaw039

Product Description:

A DP2/CRTH2 antagonist (Ki = 1.05 nM); reduces PGD2-induced eosinophil shape change (IC50s = 0.4 and 0.44 nM for isolated human eosinophils and human whole blood, respectively); inhibits PGD2-induced release of IL-5 and IL-13 in isolated human CD4+) Th2 cells (IC50s = 2.56 and 1.4 nM, respectively); reduces the number of BALF eosinophils in a mouse model of asthma (ED50 = ~1 mg/kg)

CAY20263-5 mg: Fevipiprant
CAY20263-5 mg: Fevipiprant